title: Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.
abstract: The 10th Banff Conference on Allograft Pathology was held in Banff, Canada from August 9 to 14, 2009. A total of 263 transplant clinicians, pathologists, surgeons, immunologists and researchers discussed several aspects of solid organ transplants with a special focus on antibody mediated graft injury. The willingness of the Banff process to adapt continuously in response to new research and improve potential weaknesses, led to the implementation of six working groups on the following areas: isolated v-lesion, fibrosis scoring, glomerular lesions, molecular pathology, polyomavirus nephropathy and quality assurance. Banff working groups will conduct multicenter trials to evaluate the clinical relevance, practical feasibility and reproducibility of potential changes to the Banff classification. There were also sessions on quality improvement in biopsy reading and utilization of virtual microscopy for maintaining competence in transplant biopsy interpretation. In addition, compelling molecular research data led to the discussion of incorporation of omics-technologies and discovery of new tissue markers with the goal of combining histopathology and molecular parameters within the Banff working classification in the near future.
authors.affiliation: Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. bsis@ualberta.ca
authors.forename: B
authors.initials: B
authors.lastname: Sis
authors.forename: M
authors.initials: M
authors.lastname: Mengel
authors.forename: M
authors.initials: M
authors.lastname: Haas
authors.forename: R B
authors.initials: RB
authors.lastname: Colvin
authors.forename: P F
authors.initials: PF
authors.lastname: Halloran
authors.forename: L C
authors.initials: LC
authors.lastname: Racusen
authors.forename: K
authors.initials: K
authors.lastname: Solez
authors.forename: W M
authors.initials: WM
authors.lastname: Baldwin
authors.forename: E R
authors.initials: ER
authors.lastname: Bracamonte
authors.forename: V
authors.initials: V
authors.lastname: Broecker
authors.forename: F
authors.initials: F
authors.lastname: Cosio
authors.forename: A J
authors.initials: AJ
authors.lastname: Demetris
authors.forename: C
authors.initials: C
authors.lastname: Drachenberg
authors.forename: G
authors.initials: G
authors.lastname: Einecke
authors.forename: J
authors.initials: J
authors.lastname: Gloor
authors.forename: D
authors.initials: D
authors.lastname: Glotz
authors.forename: E
authors.initials: E
authors.lastname: Kraus
authors.forename: C
authors.initials: C
authors.lastname: Legendre
authors.forename: H
authors.initials: H
authors.lastname: Liapis
authors.forename: R B
authors.initials: RB
authors.lastname: Mannon
authors.forename: B J
authors.initials: BJ
authors.lastname: Nankivell
authors.forename: V
authors.initials: V
authors.lastname: Nickeleit
authors.forename: J C
authors.initials: JC
authors.lastname: Papadimitriou
authors.forename: P
authors.initials: P
authors.lastname: Randhawa
authors.forename: H
authors.initials: H
authors.lastname: Regele
authors.forename: K
authors.initials: K
authors.lastname: Renaudin
authors.forename: E R
authors.initials: ER
authors.lastname: Rodriguez
authors.forename: D
authors.initials: D
authors.lastname: Seron
authors.forename: S
authors.initials: S
authors.lastname: Seshan
authors.forename: M
authors.initials: M
authors.lastname: Suthanthiran
authors.forename: B A
authors.initials: BA
authors.lastname: Wasowska
authors.forename: A
authors.initials: A
authors.lastname: Zachary
authors.forename: A
authors.initials: A
authors.lastname: Zeevi
mesh_terms: D000906:Antibodies / Q000737:chemistry*; D001706:Biopsy; D002170:Canada; D015935:Complement C4b / Q000378:metabolism; D005355:Fibrosis / Q000473:pathology; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis / Q000473:pathology / Q000821:virology; D016030:Kidney Transplantation; D015337:Multicenter Studies as Topic; D016377:Organ Transplantation / Q000379:methods*; D010446:Peptide Fragments / Q000378:metabolism; D010641:Phenotype; D027601:Polyomavirus Infections / Q000175:diagnosis; D011786:Quality Control
chemical_list: D000906:Antibodies; D010446:Peptide Fragments; D015935:Complement C4b; C032261:complement C4d